GLP-1 based therapies: clinical implications for gastroenterologists.

Item

http://www.wikidata.org/entity/Q38703292

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

GLP-1 based therapies: clinical implications for gastroenterologists.

@en

type

Item

label

GLP-1 based therapies: clinical implications for gastroenterologists.

@en

prefLabel

GLP-1 based therapies: clinical implications for gastroenterologists.

@en

P1476

GLP-1 based therapies: clinical implications for gastroenterologists

@en

P2093

Daniel H van Raalte

http://www.w3.org/2001/XMLSchema#string

Djuna L Cahen

http://www.w3.org/2001/XMLSchema#string

Lennart Tonneijck

http://www.w3.org/2001/XMLSchema#string

Mark H H Kramer

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin

Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Pancreatic safety of incretin-based drugs--FDA and EMA assessment

The Physiology of Glucagon-like Peptide 1

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

P304

702-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2015-310572

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark M Smits

Marcel H.A. Muskiet

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291341371

http://www.w3.org/2001/XMLSchema#string

P698

26786687

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology